Boston Biopharma Limited

About Boston Biopharma Limited

Boston Biopharma is a US-based pharmaceutical company that specializes in providing the highest quality specialty medications worldwide, in particular to emerging countries. We do this through pioneering R&D, and licensing, manufacturing, and commercializing the finest therapeutics especially oncology, multiple sclerosis, and immunology. Our EMEA operations office is located in Malta and we have a significant market presence in Algeria, Iraq, and the GCC.  With a focus on product quality and operational flexibility, our firm brings decades of healthcare industry expertise to some of the most difficult markets.

  • MT
  • 2017
    On CPHI since
Contact info
  • Malta Life Sciences Park Building 2, Level 0, SGN3000, San Gwann , Malta

Products from Boston Biopharma Limited (3)

  • Fulvestrant

    Product Fulvestrant

    Classification: antiestrogen
    Fulvestrant is pure estrogen-receptor antagonist without any known estrogen agonist effects.
    It is  is indicated for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women.

  • Goserelin

    Product Goserelin

    Goserelin is hormone therapy, classified as "LHRH agonist." (Endocrine Therapy)
    It is indicated:
    - in advanced breast cancer in pre and perimenopausal women suitable for hormonal manipulation
    - as an alternative to chemotherapy in the standard of care for pre and perimenopausal women with estrogen re...
  • Ranibizumab

    Product Ranibizumab

    This product is being developed according to ICH/EMA/FDA guidelines.

    Ranibizumab Biosimilar is a monoclonal antibody fragment that inhibits angiogenesis by inhibiting Vascular endothelial growth factor A.
    It is used for age-related wet macular...